Navigation Links
Bay of Plenty Pharmacist Found Guilty

Heather Nancy Burton of Mount Maunganui, who faced charges on 58 counts of fraud and forgery relating to prescription items has been found guilty .The trial lasted three weeks.//

A two-year investigation was conducted by the Ministry of Health and the case which lasted three weeks was tried in the Tauranga District Court.

According to reports, the prescription items were paid on behalf of the Bay of Plenty District Health Board.

Quentin Wilson from the Ministry department said, the verdict sends across a clear signal to all health providers who claim for subsidies from government, that fraud shall not be tolerated or excused.

Burton will be sentenced on February 9.
PRI
'"/>




Page: 1

Related medicine news :

1. Drinking Plenty of Water may Prevent Kidney Stones
2. April Showers Bring May Flowers – And Plenty of Pollen, To
3. Pharmacist’s Role in Medication Error
4. New Medicare Plan - Mixed Reaction among Pharmacists.
5. Manitoba Ombudsman Warns Pharmacists
6. Hospitalized patients better of with help from Pharmacists
7. Pharmacy Board Says Pharmacists Have Right To Refuse Morning-After Pill
8. Pharmacists to take over Treatment of Long-Term Illnesses
9. Alberta Pharmacists Entitled to Prescribe Medicines
10. Pharmacists Workload Contributes To Errors
11. Fluoride Found Effective in Osteoporosis
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Bay Plenty Pharmacist Found Guilty

(Date:12/4/2008)...Dec. 4 On this Interna... Women , the Pan American Health and Education Fou...al Violence Prevention project. The project has ad...y that violence is preventable. , , As pa...evention: The Investment that Saves Lives , Edward...
(Date:12/4/2008)..., Dec. 4 The Commander ...eleased the following statement concerning illegal...dical Center: , , "The men and women of The...120,000 war time veterans, are following the revel...anapolis, Roudebush VA Medical Center with dismay ...
(Date:12/4/2008)...c. 4, 2008 Use of the drug interferon as a long-t...f liver disease associated with the hepatitis C vi... researchers and their colleagues from nine other ... Results of the 3-year study, called the HALT-C (...Cirrhosis) Trial, appear in today,s issue of The ...
(Date:12/4/2008)...erto Rico, Dec. 4 Triple...nounced that it has signed a non-,binding letter ...of La Cruz,Azul de Puerto Rico, Inc. In addition...sociation to transfer the licensing rights to the ...s and Blue Shield brands in the US Virgin Islands,...
Breaking Medicine News(10 mins):Health News:PAHEF Works to Prevent Violence Against Women 2Health News:American Legion, Department of Indiana Releases Statement Concerning Revelations of Illicit Drug Trafficking at Roudebush VA Medical Center 2Health News:HALT-C researchers: Interferon as long-term treatment for hepatitis C not effective 2Health News:Triple-S Management Corporation Signs Letter of Intent to Acquire Managed Care Portfolio of La Cruz Azul de Puerto Rico, Inc. 2
...ut AIDS/HIV, the Rotarians of Malda and the distri...h awareness program// ('One step for awareness abo... specifically at barbers. The local barbers, unde...ttee, organized a rally. A special AIDS/HIV awaren...
...e of Dental and Craniofacial Research, Marquette U...nois, the Center for Disease Control, and the Nati...e progress made towards achieving the "Healthy Peo...ectives" (HP 2010) at the combined meeting of the ...
...ain foods keep triglycerides in their limits and k...udy by Agricultural Research// Service scientists ...e grains do that. According to ARS chemist Nancy L...eans of moving lipids to muscles, where they're us...
...t 79 and a war veteran, having braved all odds, wa... met his end at the hands of a// nurse, who by a q...to give him a good night’s sleep. Hull Crown Court...wfully killing Kenneth Heaton, aged 79 by giving h...
Other Medicine News:Health News:Fat fighters’: Whole-grain foods’: under the microsco 2
(Date:12/4/2008)... 4 Velos, Inc., the recognized lea...ement information systems, today announced that it...ansas Medical Center (KU Medical Center). KU Medi...hensive, system-wide roll-out that supports the re...nformation needs of the institution,s clinical res...
(Date:12/3/2008)...Dec. 3 The Leukemia & Lymphoma...e beginning of a new clinical trial of ISF35, a ca...n Diego (UCSD). , , LLS is collaborating... development and approval of a novel approach aime... and/or 17p deleted chronic lymphocytic leukemia (...
(Date:12/3/2008)...RNewswire-FirstCall/ -- Vical Incorporated,(Nasda...letter of intent with EIP,Eczacibasi Ilac Pazarla...ny,s,Allovectin-7(R) immunotherapeutic product ca...thern Cyprus. EIP has agreed to obtain the necessa...pay Vical upfront and milestone payments,plus a s...
(Date:12/2/2008)...c. 2 TorreyPines Therapeutics, Inc...ts from a 26 patient Phase II trial evaluating thr...or dry mouth, in patients with Sjogren,s syndrome....ly significant increase in salivary flow productio...5 mg, and 20 mg. These doses were safe and well to...
Breaking Medicine Technology:University of Kansas Medical Center to Deploy Velos eResearch System-Wide 2University of Kansas Medical Center to Deploy Velos eResearch System-Wide 3The Leukemia & Lymphoma Society and Memgen Announce New Chronic Lymphocytic Leukemia Clinical Trial 2The Leukemia & Lymphoma Society and Memgen Announce New Chronic Lymphocytic Leukemia Clinical Trial 3Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 2Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 3Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 4Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 5TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia 2TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia 3TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia 4TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia 5WuXi AppTec Appoints Garry Takle Ph D as VP of Operations and Joseph Hughes Ph D as VP of Testing Services for Philadelphia Facility 7184 1WuXi AppTec Appoints Garry Takle Ph D as VP of Operations and Joseph Hughes Ph D as VP of Testing Services for Philadelphia Facility 7184 2Palladium Health Selects Air Ambulance Company AirMed International as Their Official Medical Evacuation Service 25481 1Palladium Health Selects Air Ambulance Company AirMed International as Their Official Medical Evacuation Service 25481 2Experimental Apartment in Beijing Achieves 99 25 Purity of Indoor Air 25479 1Experimental Apartment in Beijing Achieves 99 25 Purity of Indoor Air 25479 2Experimental Apartment in Beijing Achieves 99 25 Purity of Indoor Air 25479 3Experimental Apartment in Beijing Achieves 99 25 Purity of Indoor Air 25479 4True properties of carbon nanotubes measured 7183 1True properties of carbon nanotubes measured 7183 2True properties of carbon nanotubes measured 7183 3
...icacy and Safety, LEXINGTON, Mass., June 07, 2007 ... Inc. today announced final results from,its Phase...e,undecanoate), a long- acting injectable testoste...f male hypogonadism which the,Company licensed fro... the recently completed 48-week trial showed that ...
...ynogen,Pharmaceuticals, Inc. reported positive res...rolled Phase 1b trial of DDP733 for,gastroesophage...o,demonstrate proof-of-concept for DDP733 as a tre... of DDP733 achieved,statistical significance over ...e number of reflux events and was safe and well,to...
Other Medicine Technology:Indevus Reports Positive Data From Phase III NEBIDO Trial 2Indevus Reports Positive Data From Phase III NEBIDO Trial 3Indevus Reports Positive Data From Phase III NEBIDO Trial 4Indevus Reports Positive Data From Phase III NEBIDO Trial 5Indevus Reports Positive Data From Phase III NEBIDO Trial 6Dynogen Reports Positive Results in Phase 1B GERD Study 2Dynogen Reports Positive Results in Phase 1B GERD Study 3Dynogen Reports Positive Results in Phase 1B GERD Study 4
The XE-2100 automated hematology analyzer features new hematology parameters as NRBC, IRF, and HPC that offer valuable and accurate clinical information.
The CKX microscopes utilize the infinity-corrected optical system for improved visibility and operability in cell checking. The CKX31 is a cost-effective inverted microscope suited to routine applica
... ergonomic concerns in mind from the lowest stage ... market. Optional tilting-telescoping observation ...cope to suit their individual needs. This ergonomi...ht, comfortable posture, especially beneficial for...
A standard laboratory microscope whose superior ergonomics, and unsurpassed optical imagery combine to make it the ideal clinical microscope. The E400 is designed to fit the user rather than forcing
Medicine Products: